Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients

British Journal of Dermatology

Volumn 169, Issue 6, 2013, Pages 1240-1245

  Ribero, S ^a,b   Osella Abate, S ^a   Sanlorenzo, M ^a   Savoia, P ^a   Astrua, C ^a   Cavaliere, G ^a   Tomasini, C ^b   Senetta, R ^a,b   Macripo G ^b   Bernengo, M G ^a   Quaglino, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IN-TRANSIT METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; THICKNESS; ULCER; COHORT ANALYSIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SKIN TUMOR; TUMOR RECURRENCE; TUMOR REGRESSION;

COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM REGRESSION, SPONTANEOUS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84889028850     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12586     Document Type: Article

References (25)

1. Ronan SG, Eng AM, Briele HA, et al,. Thin malignant melanomas with regression and metastases. Arch Dermatol 1987; 123: 1326-30.
2. Blessing K, McLaren KM, McLean A, Davidson P,. Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. Histopathology 1990; 17: 389-95.
3. Slingluff CL Jr, Seigler HF,. 'Thin' malignant melanoma: risk factors and clinical management. Ann Plast Surg 1992; 28: 89-94.
4. Guitart J, Lowe L, Piepkorn M, et al,. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol 2002; 138: 603-8.
5. Morton DL, Cochran AJ, Thompson JF, et al,. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-11.
6. Gershenwald JE, Thompson W, Mansfield PF, et al,. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-83.
7. Lourari S, Paul C, Gouraud PA, et al,. Sentinel lymph node biopsy for melanoma is becoming a consensus: a national survey of French centres involved in melanoma care in 2008. J Eur Acad Dermatol Venereol 2012; 26: 1230-5.
8. Kaur C, Thomas RJ, Desai N, et al,. The correlation of regression in primary melanoma with sentinel lymph node status. J Clin Pathol 2008; 61: 297-300.
9. Warycha MA, Zakrzewski J, Ni Q, et al,. Meta-analysis of sentinel lymph node positivity in thin melanoma (≤ 1 mm). Cancer 2009; 115: 869-79.
10. Socrier Y, Lauwers-Cances V, Lamant L, et al,. Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients. Br J Dermatol 2010; 162: 830-4.
11. Shaw HM, McCarthy SW, McCarthy WH, et al,. Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases. Histopathology 1989; 15: 257-65.
12. Ma MW, Medicherla RC, Qian M, et al,. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Mod Pathol 2012; 25: 1000-10.
13. Savoia P, Fava P, Caliendo V, et al,. Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon? J Eur Acad Dermatol Venereol 2012; 26: 242-8.
14. White RL Jr, Ayers GD, Stell VH, et al,. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 2011; 18: 3593-600.
15. Ribero S, Quaglino P, Osella-Abate S, et al,. Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. J Eur Acad Dermatol Venereol 2012; 27: 1132-7.
16. Balch CM, Gershenwald JE, Soong SJ, et al,. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-206.
17. Cochran AJ, Balda BR, Starz H, et al,. The Augsburg consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89: 236-41.
18. Sober AJ, Chuang TY, Duvic M, et al,. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001; 45: 579-86.
19. Quaglino P, Borgognoni L, Bottoni U, et al,. Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients. G Ital Dermatol Venereol 2007; 142: 41-7.
20. Garbe C, Peris K, Hauschild A, et al,. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer 2010; 46: 270-83.
21. Kang S, Barnhill RL, Mihm MC Jr, Sober AJ,. Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol 1993; 20: 126-9.
22. Requena C, Botella-Estrada R, Traves V, et al,. Problems in defining melanoma regression and prognostic implication. Actas Dermosifiliogr 2009; 100: 759-66.
23. Burton AL, Gilbert J, Farmer RW, et al,. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg 2011; 77: 1009-13.
24. Morris KT, Busam KJ, Bero S, et al,. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy. Ann Surg Oncol 2008; 15: 316-22.
25. Testori A, De Salvo GL, Montesco MC, et al,. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1313 patients (SOLISM-IMI). Ann Surg Oncol 2009; 16: 2018-27.